Communiqué de presse : Sanofi investit plus d’un milliard d’euros supplémentaires dans la production de médicaments en France, en plus des 2,5 milliards d’euros déjà engagés dans de grands projets de souveraineté sanitaire
May 13, 2024 01:00 ET
|
Sanofi - Aventis Groupe
Sanofi investit plus d’un milliard d’euros supplémentaires dans la production de médicaments en France, en plus des 2,5 milliards d’euros déjà engagés dans de grands projets de souveraineté...
Press Release: Sanofi adds over €1 billion for biomanufacturing to €2.5 billion already committed in major projects in France to support health sovereignty
May 13, 2024 01:00 ET
|
Sanofi - Aventis Groupe
Sanofi adds over €1 billion for biomanufacturing to €2.5 billion already committed in major projects in France to support health sovereignty Paris, May 13, 2024. As the largest private...
Bone Metastasis Treatment Market To Reach USD 38.5 Billion By 2032 | DataHorizzon Research
May 12, 2024 02:40 ET
|
DataHorizzon Research
Fort Collins, Colorado, May 12, 2024 (GLOBE NEWSWIRE) -- The high prevalence of cancer drives the bone metastasis treatment market. The growing prevalence of cancer worldwide is a key driver...
Merkel Cell Carcinoma Treatment Market To Reach USD 4.3 Billion By 2032 | DataHorizzon Research
May 11, 2024 03:40 ET
|
DataHorizzon Research
Fort Collins, Colorado, May 11, 2024 (GLOBE NEWSWIRE) -- The rise in skin disorders aggravates the need for merkel cell carcinoma treatment industry. The merkel cell carcinoma treatment market is...
Vaccines Market is Expected to Reach $94.9 billion | MarketsandMarkets™
May 10, 2024 08:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, May 10, 2024 (GLOBE NEWSWIRE) -- Vaccines market in terms of revenue was estimated to be worth $78.0 billion in 2024 and is poised to reach $94.9 billion by 2029, growing at a CAGR of 4.0%...
Chromoblastomycosis Treatment Market To Reach USD 1,436.6 Million By 2032 | DataHorizzon Research
May 10, 2024 03:10 ET
|
DataHorizzon Research
Fort Collins, Colorado, May 10, 2024 (GLOBE NEWSWIRE) -- The global prevalence of chromoblastomycosis treatment boosts their demand. The chromoblastomycosis treatment market is on an upward...
Communiqué de presse : Sanofi et Novavax concluent un accord de licence co-exclusif pour la co-commercialisation d’un vaccin COVID-19 et le développement de vaccins combinés grippe - COVID-19
May 10, 2024 02:00 ET
|
Sanofi - Aventis Groupe
Sanofi et Novavax concluent un accord de licence co-exclusif pour la co-commercialisation d’un vaccin COVID-19 et le développement de vaccins combinés grippe - COVID-19 L’accord, qui combinera la...
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines
May 10, 2024 02:00 ET
|
Sanofi - Aventis Groupe
Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines Agreement provides patients with broader...
Alcoholic Hepatitis Treatment Market To Reach USD 4.9 Billion By 2032 | DataHorizzon Research
May 09, 2024 14:10 ET
|
DataHorizzon Research
Fort Collins, Colorado, May 09, 2024 (GLOBE NEWSWIRE) -- The growing prevalence of alcohol-related liver diseases drives the demand for alcoholic hepatitis treatment in the forecast period. The...
Psoriasis Vulgaris Clinical Trial Pipeline Analysis Demonstrates 50+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight
May 09, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, May 09, 2024 (GLOBE NEWSWIRE) -- Psoriasis Vulgaris Clinical Trial Pipeline Analysis Demonstrates 50+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm,...